mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.004 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.005 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.007 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |